| 000 | 01523 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513123354.0 | ||
| 264 | 0 | _c19970915 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0149-5992 | ||
| 024 | 7 |
_a10.2337/diacare.20.8.1252 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEliasson, M | |
| 245 | 0 | 0 |
_aProinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study. _h[electronic resource] |
| 260 |
_bDiabetes care _cAug 1997 |
||
| 300 |
_a1252-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 |
_aFibrinolysis _xphysiology |
| 650 | 0 | 4 |
_aGlucose Intolerance _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperinsulinism _xblood |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xblood |
| 650 | 0 | 4 |
_aProinsulin _xblood |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSweden |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xblood |
| 700 | 1 | _aRøder, M E | |
| 700 | 1 | _aDinesen, B | |
| 700 | 1 | _aEvrin, P E | |
| 700 | 1 | _aLindahl, B | |
| 773 | 0 |
_tDiabetes care _gvol. 20 _gno. 8 _gp. 1252-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diacare.20.8.1252 _zAvailable from publisher's website |
| 999 |
_c9230178 _d9230178 |
||